Skip to main content
logo
Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.310
-0.190 (-4.22%)
At close: Mar 27, 2026, 4:00 PM EDT
4.330
+0.020 (0.46%)
After-hours: Mar 27, 2026, 7:29 PM EDT

Bicycle Therapeutics Revenue

In the year 2025, Bicycle Therapeutics had annual revenue of $72.59M with 105.77% growth. Bicycle Therapeutics had revenue of $47.96M in the quarter ending December 31, 2025, with 1,193.28% growth.

Revenue (ttm)
$72.59M
Revenue Growth
+105.77%
P/S Ratio
4.14
Revenue / Employee
$252,035
Employees
288
Market Cap
300.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.59M37.31M105.77%
Dec 31, 202435.28M8.30M30.76%
Dec 31, 202326.98M12.51M86.52%
Dec 31, 202214.46M2.77M23.65%
Dec 31, 202111.70M1.31M12.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Puma Biotechnology228.37M
Opus Genetics14.20M
Ovid Therapeutics7.25M
AC Immune4.51M
Surrozen3.48M
Neurogene925.00K
Avalo Therapeutics59.00K
Revenue Rankings

BCYC News

More News